Standout Papers
Immediate Impact
18 standout
Citing Papers
Bispecific antibodies: advancing precision oncology
2024 Standout
Targeting cytokine and chemokine signaling pathways for cancer therapy
2024 Standout
Works of Yang Ou being referenced
Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials
2020
Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU+P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC).
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yang Ou | 85 | 57 | 18 | 52 | 24 | 240 | |
| Huan Wang | 58 | 36 | 11 | 29 | 30 | 255 | |
| Ping Li | 75 | 19 | 24 | 53 | 21 | 291 | |
| Philipp Berning | 57 | 22 | 63 | 42 | 21 | 224 | |
| Yasuhiko Nakao | 82 | 25 | 19 | 26 | 29 | 243 | |
| Kiyoko Inui | 105 | 40 | 17 | 21 | 18 | 289 | |
| Masashi Sada | 153 | 88 | 23 | 73 | 20 | 294 | |
| Hongmu Li | 100 | 72 | 12 | 40 | 20 | 228 | |
| María N. Barrachina | 111 | 67 | 8 | 30 | 20 | 285 | |
| Lei Li | 114 | 43 | 10 | 36 | 29 | 265 | |
| Chun Huang | 93 | 64 | 12 | 24 | 19 | 249 |
All Works
Login with ORCID to disown or claim papers
Loading papers...